Literature DB >> 15138941

Oral solid form of primary effusion lymphoma mimicking plasmablastic lymphoma.

José-Luis Mate1, José-Tomás Navarro, Aurelio Ariza, Josep-Maria Ribera, Eva Castellà, Jordi Juncà, Cristina Tural, José-Francisco Nomdedeu, Beatriz Bellosillo, Sergi Serrano, Isabel Granada, Fuensanta Millá, Evarist Feliu.   

Abstract

Primary effusion lymphoma (PEL) is a rare large cell lymphoma subtype that usually is associated with human immunodeficiency virus infection. Features facilitating PEL identification are its clinical presentation, cytologic findings, immunophenotypic profile, and particularly, relation to human herpesvirus 8 (HHV8) infection. Uncommonly, PEL may present as a solid form that predominantly involves the distal digestive tract and poses major diagnostic problems, especially when unassociated with body cavity effusions. We herein report the case of an HIV-positive 42-year-old male with synchronous presentation of a pleural cavity PEL and a tongue-based lesion, both displaying plasmablastic features. Demonstration of HHV8 presence in the lingual lesion excluded a plasmablastic lymphoma and established the diagnosis of an oral solid form of PEL. This case illustrates the need for investigating HHV8 in any plasmablastic-looking lymphoma, especially in HIV-infected patients.

Entities:  

Mesh:

Year:  2004        PMID: 15138941     DOI: 10.1016/j.humpath.2003.11.005

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  KSHV/HHV-8 associated lymph node based lymphomas in HIV seronegative subjects. Report of two cases with anaplastic large cell morphology and plasmablastic immunophenotype.

Authors:  A Carbone; A Gloghini; E Vaccher; G Marchetti; G Gaidano; U Tirelli
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

Review 2.  Diffuse large B-cell lymphomas with plasmablastic differentiation.

Authors:  Julie Teruya-Feldstein
Journal:  Curr Oncol Rep       Date:  2005-09       Impact factor: 5.075

3.  HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3.

Authors:  Amy Chadburn; Jonathan Said; Dita Gratzinger; John K C Chan; Daphne de Jong; Elaine S Jaffe; Yasodha Natkunam; John R Goodlad
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

Review 4.  Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece.

Authors:  E Campo; A Chott; M C Kinney; L Leoncini; C J L M Meijer; C S Papadimitriou; M A Piris; H Stein; S H Swerdlow
Journal:  Histopathology       Date:  2006-04       Impact factor: 5.087

5.  A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway.

Authors:  Wan Li; Xuemei Jia; Chenyou Shen; Mi Zhang; Jingyun Xu; Yuancui Shang; Kaixiang Zhu; Minmin Hu; Qin Yan; Di Qin; Myung-Shin Lee; Jianzhong Zhu; Hongmei Lu; Brian J Krueger; Rolf Renne; Shou-Jiang Gao; Chun Lu
Journal:  Oncotarget       Date:  2016-05-31

6.  An aggressive form of non-Hodgkin's lymphoma with pleural and abdominal chylous effusions: A case report and review of the literature.

Authors:  Yajian Jiang; Wanzhuo Xie; Keyue Hu; Jie Sun; Xiaoli Zhu; He Huang
Journal:  Oncol Lett       Date:  2013-07-29       Impact factor: 2.967

7.  Monomorphic post-transplant lymphoproliferative disorder of the tongue: case report and review of literature.

Authors:  Luis F Gonzalez-Cuyar; Fabio Tavora; Allen P Burke; Christopher D Gocke; Ann Zimrin; John J Sauk; Xiafeng F Zhao
Journal:  Diagn Pathol       Date:  2007-12-19       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.